ProShares Ultra Health Care
26 hedge funds and large institutions have $22.7M invested in ProShares Ultra Health Care in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
46% more capital invested
Capital invested by funds: $15.6M → $22.7M (+$7.14M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
5.5% more ownership
Funds ownership: 19.85% → 25.35% (+5.5%)
4% more funds holding
Funds holding: 25 → 26 (+1)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$7.01M |
| 2 |
PFA
Plotkin Financial Advisors
Chevy Chase,
Maryland
|
+$699K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$419K |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$245K |
| 5 |
IC
IEQ Capital
Foster City,
California
|
+$204K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.49M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.38M |
| 3 |
IMC Chicago
Chicago,
Illinois
|
-$1.1M |
| 4 |
SI
Sprott Inc
Toronto,
Ontario, Canada
|
-$450K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$131K |
RXL Hedge Fund Activity: Q4 2021 in Review
26 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q4 2021, worth a combined $22.7M — up 46% from $15.6M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new RXL positions and 6 closed out — a net gain of 1 holder — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Geneos Wealth Management, opening a new position worth an estimated $7.01M. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.49M sold.
- 26 institutional investors held ProShares Ultra Health Care (RXL) as of Q4 2021, up from 25 in Q3 2021.
- Funds reported $22.7M of ProShares Ultra Health Care stock for Q4 2021, up 46% quarter-over-quarter.
- 7 funds opened new ProShares Ultra Health Care positions in Q4 2021 and 6 closed out, a net change of +1 holder.
- The largest ProShares Ultra Health Care buyer in Q4 2021 was Geneos Wealth Management, an estimated $7.01M added.
- The largest ProShares Ultra Health Care seller in Q4 2021 was Citadel Advisors, an estimated $1.49M sold.
Based on aggregated 13F filings for Q4 2021.